Price $33.11 |
Market Cap
337M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
27.2
|
P/B
2.7
|
P/S
0.69
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
37.6
|
Op. Cash Flow
19.7K
|
FCF
0.3
|
|
Op. Margin
4.80%
|
Net Margin
2.60%
|
ROE
10.60%
|
ROI
6.00%
|
|
ROA
2.50%
|
EPS Growth
588.20%
|
Current Ratio
1.1
|
Debt/Equity
52.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
